Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Articles published by AscellaHealth, LLC

Announcing the 2025 Philadelphia Titan 100 Recipients
From AscellaHealth, LLC
Via GlobeNewswire
AscellaHealth to Present on Site of Care Strategies for High-Cost Medications at SIIA Stakeholder Forum
From AscellaHealth, LLC
Via GlobeNewswire
AscellaHealth Awarded on the Financial Times Americas’ Fastest Growing Companies 2025 List!
From AscellaHealth, LLC
Via GlobeNewswire
AscellaHealth Honored as Silver Stevie® Award Winner in 2025 American Business Awards®
From AscellaHealth, LLC
Via GlobeNewswire
AscellaHealth Demonstrates Leadership in Realizing the Full Potential of Novel Therapies and Medicinal Products at Advanced Therapies Integrates North 2025
From AscellaHealth, LLC
Via GlobeNewswire
Actum Pharma Expands Executive Team to Launch Enhanced Services Program to Support Biopharma Product Commercialization and Market Success
From AscellaHealth, LLC
Via GlobeNewswire
AscellaHealth Announces Key Executive Promotions, Supporting Strategic Growth in the Life Sciences Business Unit
From AscellaHealth, LLC
Via GlobeNewswire
AscellaHealth Showcases Rare Disease Expertise and Comprehensive Specialty Pharmaceutical Solutions at World Orphan Drug Congress USA 2025
From AscellaHealth, LLC
Via GlobeNewswire
AscellaHealth Releases Q1 2025 Specialty & Rare Pipeline Digest™ Providing Essential Clinical Drug Updates
From AscellaHealth, LLC
Via GlobeNewswire
Optime Care Partners with Eton Pharmaceuticals as a Specialty Pharmacy Provider for GALZIN®
From AscellaHealth, LLC
Via GlobeNewswire
AscellaHealth Supports Rare Disease Patients and Caregivers in Observance of Rare Disease Day, February 28
From AscellaHealth, LLC
Via GlobeNewswire
AscellaHealth Expands Leadership Team to Accelerate Growth, Strengthen Operations and Advance Patient-Centric Solutions
From AscellaHealth, LLC
Via GlobeNewswire
AscellaHealth Releases Q4 2024 Specialty & Rare Pipeline Digest™ Featuring Key Specialty Drug, Biosimilar, Cell and Gene Therapy Approvals
From AscellaHealth, LLC
Via GlobeNewswire
AscellaHealth Ranked Number 154 Fastest-Growing Company in North America on the 2024 Deloitte Technology Fast 500™
From AscellaHealth, LLC
Via GlobeNewswire
AscellaHealth Releases Q3 2024 Specialty & Rare Pipeline Digest™: FDA-Approved Biosimilars Outpaces Cell and Gene Therapy Amid Complex Regulatory Challenges
From AscellaHealth, LLC
Via GlobeNewswire
Optime Care Expands Partnership with Rigel Pharmaceuticals to Include Commercial Distribution for TAVALISSE®
From AscellaHealth, LLC
Via GlobeNewswire
Tickers RIGL
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.